Uric acid enhances alteplase-mediated thrombolysis as an antioxidant.
Uric acid enhances alteplase-mediated thrombolysis as an antioxidant.
复制标题
DOI:
10.1038/s41598-018-34220-1
复制
发表时间:
2018-10-26
影响因子:
4.6
通讯作者:
Tancharoen S
中科院分区:
文献类型:
--
作者:
Kikuchi K;Setoyama K;Tanaka E;Otsuka S;Terashi T;Nakanishi K;Takada S;Sakakima H;Ampawong S;Kawahara KI;Nagasato T;Hosokawa K;Harada Y;Yamamoto M;Kamikokuryo C;Kiyama R;Morioka M;Ito T;Maruyama I;Tancharoen S
Uric acid (UA) therapy may prevent early ischemic worsening after acute stroke in thrombolysis patients. The aim of this study was to examine the influence of UA on the thrombolytic efficacy of alteplase in human blood samples by measuring thrombolysis under flow conditions using a newly developed microchip-based flow-chamber assay. Human blood samples from healthy volunteers were exposed to UA, alteplase, or a combination of UA and alteplase. Whole blood and platelet-rich plasma were perfused over a collagen- and thromboplastin-coated microchip, and capillary occlusion was monitored with a video microscope and flow-pressure sensor. The area under the curve (extent of thrombogenesis or thrombolysis) at 30 minutes was 92% lower in the UA–alteplase-treated group compared with the alteplase-treated group. D-dimers were measured to evaluate these effects in human platelet-poor plasma samples. Although hydrogen peroxide significantly decreased the elevation of D-dimers by alteplase, UA significantly inhibited the effect of hydrogen peroxide. Meanwhile, rat models of thromboembolic cerebral ischemia were treated with either alteplase or UA–alteplase combination therapy. Compared with alteplase alone, the combination therapy reduced the infarct volume and inhibited haemorrhagic transformation. UA enhances alteplase-mediated thrombolysis, potentially by preventing oxidative stress, which inhibits fibrinolysis by alteplase in thrombi.
登录
查看更多内容
DOI:
10.1177/0271678x17709185
发表时间:
2017-11
期刊:
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
影响因子:
--
作者:
Percie du Sert N;Alfieri A;Allan SM;Carswell HV;Deuchar GA;Farr TD;Flecknell P;Gallagher L;Gibson CL;Haley MJ;Macleod MR;McColl BW;McCabe C;Morancho A;Moon LD;O'Neill MJ;Pérez de Puig I;Planas A;Ragan CI;Rosell A;Roy LA;Ryder KO;Simats A;Sena ES;Sutherland BA;Tricklebank MD;Trueman RC;Whitfield L;Wong R;Macrae IM
通讯作者:
Macrae IM
影响因子:
2.1
作者:
Lukic-Panin, Violeta;Deguchi, Kentaro;Abe, Koji
通讯作者:
Abe, Koji
影响因子:
3.7
作者:
Traby, Ludwig;Kollars, Marietta;Kyrle, Paul A.
通讯作者:
Kyrle, Paul A.
影响因子:
8.3
作者:
Amaro, Sergio;Soy, Dolors;Chamorro, Angel
通讯作者:
Chamorro, Angel
DOI:
10.1124/jpet.108.149484
发表时间:
2009-06-01
影响因子:
3.5
作者:
Kikuchi, Kiyoshi;Kawahara, Ko-ichi;Maruyama, Ikuro
通讯作者:
Maruyama, Ikuro